Roflumilast: APTA 2217, B9302-107, BY 217, BYK 20869

ISSN： 1174-5886

Source： Drugs in R&D, Vol.5, Iss.3, 2004-01, pp. : 176-181

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effect of Fluvoxamine on the Pharmacokinetics of Roflumilast and Roflumilast N -Oxide

By Oliver von Richter

Clinical Pharmacokinetics, Vol. 46, Iss. 7, 2007-01 ,pp. : 613-622

Adis International

Access to resources Recommend Favorite

Pharmacokinetic evaluation of roflumilast

By Lahu Gezim Nassr Nassr Hünnemeyer Andreas

Expert Opinion on Drug Metabolism and Toxicology, Vol. 7, Iss. 12, 2011-12 ,pp. : 1577-1591

Informa Healthcare

Access to resources Recommend Favorite

Reminder of roflumilast psychiatric ADRs

Reactions Weekly, Vol. 1, Iss. 1386, 2012-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Roflumilast a real contender for COPD

Inpharma, Vol. 1, Iss. 1548, 2006-01 ,pp. : 7-8

Adis International

Access to resources Recommend Favorite

Roflumilast promising in COPD and asthma

Inpharma, Vol. 1, Iss. 1364, 2002-01 ,pp. : 9-10

Adis International

Access to resources Recommend Favorite